Skip to main content

Latest SEC Filings — Page 54

Page 54 · 30 filings scored 7+ · newest 5:00 PM ET · How scores work

Mon, Oct 2630 filings
7FLDFold Holdings, Inc.Fold Stockholders Approve Reverse Split of Up to 1-for-50Form 8-K · Current report● Neutral8WRAPWrap Technologies, Inc.Wrap Proxy Amendment Adds Delatorre Nominee; Seeks 300M Authorized Shares and Series C Conversion ApprovalPRER14A · Proxy▼ NegativePro8CRMLCritical Metals Corp.Court Approves Critical Metals' European Lithium Schemes; Shares Issue November 5Form 6-K · Current report▲ PositivePro7ZEOZeo Energy Corp.Zeo Energy Secures 180-Day Nasdaq Extension to April 19, 2027 on $1.00 Bid PriceForm 8-K · Current report▼ Negative7BOHBank of Hawaii CorporationBank of Hawaii Q3 10-Q: $1.49 EPS Confirmed; NPAs Jump to $43.4M on One Commercial MortgageForm 10-Q · Periodic report● Neutral8RLYBRallybio CorpRallybio Declares $13.56/Share Special Cash Distribution Tied to Avenzo MergerForm 8-K · Current report● NeutralPro7GNVRGenvor IncGenvor Secures Full Ownership of ~9,000-Peptide Library From Founder/CSO Ahead of Nasdaq PushForm 8-K · Current report▲ Positive7WLFCWillis Lease Finance CorporationWLFC Seeks Stockholder Approval to Reincorporate in Nevada at December 15 Special MeetingPRE 14A · Proxy● Neutral8SAFXXCF Global, Inc.45.3% Holder EEME Pushes $200M Recapitalization, Vows to Oppose Reverse SplitSchedule 13D/A · Ownership stake● NeutralPro8TRAWTraws Pharma, Inc.Traws Registers Resale of 135.1M Shares Behind $50M Roth Equity LineForm S-1 · Offering▼ NegativePro8DSYBig Tree Cloud Holdings LtdBig Tree Cloud FY2026: Revenue Halved to $0.6M, Net Loss $3.7M, Two Material Weaknesses DisclosedForm 20-F · Periodic report▼ NegativePro7LGVNLongeveron Inc.Longeveron's Failed ELPIS II Trial Delivers Significant MACE Benefit; FDA Meeting PlannedForm 8-K · Current report▲ Positive7CVSICV Sciences, Inc.CV Sciences Settles Former Counsel Arbitration, Receives $500,000 CashForm 8-K · Current report▲ Positive8CPIXCumberland Pharmaceuticals Inc.Cumberland to File Rolling NDA for Ifetroban in DMD Cardiomyopathy Despite FDA Efficacy ConcernsForm 8-K · Current report▲ PositivePro7PTORPraetorian Acquisition Corp.Praetorian SPAC Replaces Four Directors and CFO in Planned Leadership TransitionForm 8-K · Current report● Neutral8WEAVWeave Communications, Inc.Weave Closes $7.40/Share Francisco Partners Buyout; Stock Delisted from NYSEForm 8-K · Current report● NeutralPro8WHLRWheeler Real Estate Investment Trust, Inc.Wheeler REIT Sets 1-for-6 Reverse Split for Oct 29; Issues 1.2M Shares in Preferred ExchangesForm 424B3 · Offering▼ NegativePro7SLBTSL Science Holding LtdSL Science Posts H1 2026: Revenue Up 23%, Net Loss Widens to $2.16MForm 6-K · Current report▼ Negative8NEWHNewHydrogen, Inc.NewHydrogen Raises $3M From SunHydrogen at $0.01473/Share Plus 407.3M WarrantsForm 8-K · Current report▼ NegativePro7CTYCity Therapeutics, Inc.ARCH Venture Discloses 25.6% Stake in City Therapeutics After $30M IPO-Era BuyingSchedule 13D · Ownership stake● Neutral8FSUNFirstSun Capital BancorpFirstSun Swings to $38.4M Q3 Profit, Guides Q4 NIM to Mid-3.80sForm 8-K · Current report▲ PositivePro7AESIAtlas Energy Solutions Inc.Atlas Energy Seeks Stockholder Approval to Reincorporate in TexasPRE 14A · Proxy● Neutral7HTOH2O AmericaH2O America 10-Q: Q3 EPS Falls to $0.99 on Higher Share Count; Quadvest Closed for $542.7MForm 10-Q · Periodic report● Neutral7HITHealth In Tech, Inc.Health In Tech Names Sanjay Shrestha CEO; Founder Moves to Executive ChairmanForm 8-K · Current report● Neutral7DORMDorman Products, Inc.Dorman Q3 Adjusted EPS Down 21%; 2026 Sales Growth Guidance Narrowed to 2%-3%Form 8-K · Current report▼ Negative7LAZLazard, Inc.Lazard Q3 10-Q: Net Income $29.2M as Compensation Costs Squeeze Advisory MarginsForm 10-Q · Periodic report▼ Negative7NPBNorthpointe Bancshares, Inc.Northpointe Board Authorizes $30 Million Buyback Through October 2027Form 8-K · Current report▲ Positive8MAASMaase Inc.Maase FY2026 20-F: RMB183M Revenue, RMB1.84B Discontinued-Ops Loss, US$13.5M Arbitration SecurityForm 20-F · Periodic report▼ NegativePro7MCRBSeres Therapeutics, Inc.Seres Therapeutics CFO Marella Thorell to Resign Effective November 15, 2026Form 8-K · Current report▼ Negative7CCXIChurchill Capital Corp XIAgility Robotics Adds Three Manufacturing Customers and a 30+ Prospect Pipeline Ahead of CCXI MergerForm 425 · Proxy▲ Positive
How Wiseek picks and scores these

How Wiseek curates this list

Every filing on this page is sourced directly from SEC EDGAR, the U.S. Securities and Exchange Commission's public filings system. Wiseek processes 8-K, 10-K, 10-Q, Form 4, Form 144, DEF 14A, Schedule 13D/A and related disclosures filed by U.S.-listed companies. The original filing is always linked from each article so readers can verify the source document directly.

How filings get scored

Each filing runs through Wiseek's importance scorer, which weights filing type, deal magnitude, insider participation, material-event flags (going-concern, restatements, executive transitions, M&A) and historical market-reaction patterns. Filings scoring below 7 on the 1–10 scale are filtered out at the database query so this list stays focused on market-moving disclosures. See our methodology for the full rubric.

Editorial standards

Wiseek does not edit the underlying SEC filing. Plain-English summaries and key-event extractions are generated from the verified source text and clearly attributed as AI-generated. Wiseek does not provide investment advice — see our editorial policy for full standards on accuracy, source disclosure, and corrections.

Track by company

Follow all SEC filings for a specific company by visiting its ticker page: AAPL, MSFT, NVDA, TSLA, AMZN, GOOGL, META, JPM, V, UNH, XOM, AVGO, LLY, MA, COST, JNJ, PG, HD, ABBV, MRK, KO, NFLX, AMD, WMT, CVX, BAC — or browse all covered tickers.